Pharmacy World and Science

, Volume 18, Issue 6, pp 211–216 | Cite as

Time-dependent variability of chloroquine secretion into human saliva

  • Cyprian O. Onyeji
  • Festus A. Ogunbona


Chloroquine has been reported to be secreted into human saliva. This is a report of a study designed to underscore the importance of the finding. It involved the administration of 600 mg chloroquine per oral to seven volunteers and 150 my by intramuscular route to six others. Blood and simultaneous saliva samples were collected and analyzed for the drug by an HPLC method. The results showed that chloroquine reaches peak concentration at the same time in both plasma and saliva after oral administration of the drug. A good correlation was obtained between the AUC values derived from saliva and plasma level data. Saliva to plasma concentration ratios obtained after administration of the drug by both routes were high (mean>11) and exhibited a time-dependerit variability. These results suggest that an active process, among other mechanisms, may be invobred in the transter of chloroquine into human saliva. Caution should be exercised in the use of salva for therapetic monitoring of chloroquine.


Chloroquine Saliva Human 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Remington's Pharmaceutical Sciences (18th edition). Mack Publishing Company, Easton, Pennsylvania, U.S.A. (1990) pp 1225–1226.Google Scholar
  2. 2.
    MartinSB, WanSH, KaramJH. Pharmacokinetics of tolbutamide in saliva: prediction by concentration in saliva. Clin Pharmacol Ther 1975;15:1052–8.Google Scholar
  3. 3.
    FraserHS, MucklowJC, MurrayS, DaviesDS. Assessment of antipyrine kinetics by measurement in saliva. Br J Clin Pharmacol 1976;3:321–5.Google Scholar
  4. 4.
    HorningMC, BrownL, NowlinJ, KellawayP, ZionTE. Use of saliva in therapeutic drug monitoring. Clin Chem 1977; 23:157–64.Google Scholar
  5. 5.
    DrobitchRK, SvenssonCK. Therapeutic drug monitoring in saliva; An Update. Clin Pharmacokinet 1992;23(5):365–79.Google Scholar
  6. 6.
    OgunbonaFA, LawalAA, OnyejiCO. Saliva excretion of chloroquine. J Pharm Pharmacol 1986;38:535–7.Google Scholar
  7. 7.
    EtteEl, EssienEE, Brown-AwalaEA. Pharmacokinetics of chloroquine: saliva and plasma level relationship. Eur J Drug Metab Pharmacokinet 1986;11:275–81.Google Scholar
  8. 8.
    Brown-AwalaEA, ThomasWOA, EssienEE, EtteEl. Determination of saliva: total plasma chloroquine levels relationship by high performance liquid chromatography. J Clin Pharmacol 1989;29:1135–9.Google Scholar
  9. 9.
    OnyejiCO, DixonPAF, OgunbonaFA. An in vitro study of chloroquine transport in the rat submaxillary gland. J Pharm Pharmacol 1992;44:136–8.Google Scholar
  10. 10.
    OgunbonaFA, OnyejiCO, LawalAA, ChukwuaniCM, BolajiOO. Liquid chromatographic analysis of chloroquine and desethylchloroquine in human plasma, saliva and urine. J Chromatogr 1986;380:420–30.Google Scholar
  11. 11.
    PostiJ. Saliva-plasma drug concentration ratios during absorption: Theoretical considerations and pharmacokinetic implications. Pharm Acta Helv 1982;57:278–92.Google Scholar
  12. 12.
    GaleazziRL, BenetLZ, SheinerLB. Relationship between the pharmacokinetics and pharmacodynamics of procainamide. Clin Pharmacol Ther 1976;20:278–89.Google Scholar
  13. 13.
    AderounmuAF, SalakoLA, LindstromB, WalkerO, EkmanL. Comparison of the pharmacokinetics of chloroquine after single intravenous and intramuscular administration in healthy Africans. Br J Clin Pharmacol 1986;22:559–564.Google Scholar
  14. 14.
    Frisk-HolmbergM, BergqvistY. Chloroquine disposition in man. Br J Clin Pharmacol 1982;14(Suppl):624–626.Google Scholar
  15. 15.
    MucklowJC, BendingMR, KahnGC, DolleyCT. Drug concentration in saliva. Clin Pharmacol Ther 1978;24:563–70.Google Scholar
  16. 16.
    DawesC, KendallMJ, JohnVA. Comparison of plasma and saliva levels of metoprolol and exprenolol. Br J Clin Pharmacol 1978;5:217–21.Google Scholar
  17. 17.
    JohnsonBF, ShekaV, WoodmanT, CanadaAT. Salivary concentration of permenol as a possible cause of the unpleasant taste. Br J Clin Pharmacol 1986;22:613–5.Google Scholar
  18. 18.
    GustafssonLL, WalkerO, AlvanG et al. Disposition of chloroquine in man after a single intravenous and oral doses. Br J Clin Pharmacol 1983;15:471–9.Google Scholar
  19. 19.
    AdelusiSA, DawoduAH, SalakoLA. Kinetics of the uptake and elimination of chloroquine in children with malaria. Br J Clin Pharmacol 1982;14:483–7.Google Scholar
  20. 20.
    YagonA, GinsburgH. The transport of chloroquine across erythrocytes membrane is mediated by a simple symmetric carrier. Biochem Biophys Acta 1982;686:197–203.Google Scholar
  21. 21.
    FerrariV, CutlerDJ. The pH dependence of chloroquine uptake by phosphotidylcholine vesicles. J Pharm Pharmacol 1986;38:761–3.Google Scholar
  22. 22.
    GibaldiM, PrescottL. eds. Handbook of Clinical Pharmacokinetics. Australia: Adis Health Science Press, 1984: Section iv, 207–27.Google Scholar
  23. 23.
    MaclntyreAC, CutlerDJ. Role of lysosome in hepatic accumulation of chloroquine. J Pharm Sci 1988; 77: 196–9.Google Scholar
  24. 24.
    OgunbonaFA, OnyejiCO, BolajiOO, TorimiroSEA. Excretion of chloroquine and desethylchloroquine into human milk. Br J Clin Pharmacol 1987;23:473–76.Google Scholar
  25. 25.
    RitschelWA, ThompsonGA. Monitoring of drug concentrations in saliva: a non-invasive pharmacokinetic procedure. Meth Find Exp Clin Pharmacol 1983;5:511–25.Google Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • Cyprian O. Onyeji
    • 1
  • Festus A. Ogunbona
    • 1
  1. 1.Department of Pharmaceutical Chemistry, Faculty of PharmacyObatemi Awolowo UniversityIle-lfeNigeria

Personalised recommendations